Cite
HARVARD Citation
Panaccione, R. et al. (n.d.). DOP065 Long-term cost-effectiveness of tight control for Crohn's disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial. Journal of Crohn's and colitis. pp. S074-S075. [Online].